The Role of Colonoscopy in the Diagnosis of Colorectal Cancer
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Causes, Screening and Diagnosis".
Deadline for manuscript submissions: 22 November 2024 | Viewed by 824
Special Issue Editor
Special Issue Information
Dear Colleagues,
Colorectal cancer (CRC) represents one of the most common causes of cancer mortality globally, with an increased proportion of newly diagnosed cases. Thus far, colonoscopy remains a valuable tool for the early detection of CRC and the removal of premalignant lesions. Indeed, this procedure significantly contributes to reducing cancer-related morbidity and mortality by detecting CRC at early stages and preventing any delayed treatment. Since CRC remains a preventable disease, effective screening methods, particularly colonoscopy, are highly recommended. Such screening strategies may help lower the risk of developing colorectal carcinomas in young or older adults. Risk stratification for CRC screening appears to be a significant step towards establishing a timely diagnosis and substantially improving patient outcomes. Interestingly, colonoscopy can contribute to the early detection of CRC by preventing the adenoma–carcinoma sequence and other eventually premalignant conditions, including inflammatory bowel diseases, such as ulcerative colitis and Crohn’s disease. Currently, great attention is being paid to post-colonoscopy CRC and its potential causal factors. This Special Issue aims to highlight the role of colonoscopy in CRC prevention and diagnosis at an early stage, even among patients with premalignant conditions. Factors associated with an increased risk of developing post-colonoscopy CRC require further research. In this Special Issue, original research articles and review papers are welcome. We look forward to receiving your contributions.
Prof. Dr. Constantinos E. Simopoulos
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- colonoscopy
- colorectal cancer (CRC)
- colorectal polyps
- ulcerative colitis
- Crohn’s disease
- post-colonoscopy colorectal cancer
- colorectal cancer screening
- risk stratification
- young patients
- elderly patients